Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.50 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 5/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.45 |
| ▸ | LMNA | P02545 | 3/20 | 0.45 |
| ▸ | PKM | P14618 | 1/20 | 0.45 |
| ▸ | TERT | O14746 | 1/20 | 0.44 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.43 |
| ▸ | APEX1 | P27695 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.41 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1415165 | 0.87 | SMN1; SMN2 (0.47) | ALOX5PTGS2POLBALDH1A1SMN1; SMN2 | |
| SCHEMBL23403562 | 0.86 | PTGS2 (0.66) | ALOX5PTGS2EPHX2 | |
| SCHEMBL20846589 | 0.85 | TERT (0.58) | ALOX5PTGS2POLBALDH1A1SMN1; SMN2 | |
| SCHEMBL5803930 | 0.84 | ALDH1A1 (0.42) | ALOX5PTGS2POLBALDH1A1SMN1; SMN2 | |
| SCHEMBL23400020 | 0.83 | SMN1; SMN2 (0.58) | ALOX5PTGS2POLBALDH1A1SMN1; SMN2 | |
| SCHEMBL7890087 | 0.83 | ALDH1A1 (0.64) | ALOX5PTGS2POLBALDH1A1SMN1; SMN2 | |
| SCHEMBL14383433 | 0.80 | ALOX5 (0.44) | ALOX5PTGS2POLBALDH1A1SMN1; SMN2 | |
| SCHEMBL12653972 | 0.80 | CASP6 (0.50) | ALOX5PTGS2POLBSMN1; SMN2RXFP1 | |
| SCHEMBL5103396 | 0.80 | ALOX5 (0.41) | ALOX5PTGS2POLBALDH1A1SMN1; SMN2 | |
| SCHEMBL5365534 | 0.80 | ALOX5 (0.41) | ALOX5PTGS2POLBALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6548647-B2 | Spraying coupling components in solution or suspension to collide in reactor chamber, then pressurizing to remove; useful for offset printing inks | CLARIANT GMBH (DE) | 2003-04-15 | — | — | US | claimed |
| US-20020055619-A1 | Process for preparing azo colorants | CLARIANT GMBH | 2002-05-09 | — | — | US | claimed |
| EP-1195411-A1 | Process for the preparation of azo colourants | Clariant GmbH (DE) | 2002-04-10 | — | — | EP | claimed |
| US-8382857-B2 | Method for the reactive coloration of leather | BASF SE (DE) | 2013-02-26 | — | — | US | disclosed |
| US-8372161-B2 | Method for the reactive coloring of leather | BASF SE (DE) | 2013-02-12 | — | — | US | disclosed |
| US-7985266-B2 | Keratin dyeing compositions comprising a radical scavenger and a chelant and use thereof | THE PROCTER & GAMBLE COMPANY (US) | 2011-07-26 | — | — | US | disclosed |
| US-20110035886-A1 | Keratin Dyeing Compositions Comprising a Radical Scavenger and a Chelant and Use Thereof | NOXELL CORPORATION | 2011-02-17 | — | — | US | disclosed |
| EP-2251385-A1 | Pyrazolone bisazo dyes | Clariant International Ltd. (CH) | 2010-11-17 | — | — | EP | disclosed |
| EP-2251386-A1 | Pyrazolone bisazo dyes | Clariant International Ltd. (CH) | 2010-11-17 | — | — | EP | disclosed |
| EP-2251381-A1 | Monoazo compounds | Clariant International Ltd. (CH) | 2010-11-17 | — | — | EP | disclosed |
| EP-1756355-B1 | METHOD FOR THE REACTIVE COLORATION OF LEATHER | BASF SE (DE) | 2010-08-25 | — | — | EP | disclosed |
| US-5093484-A | Water soluble; colorfast shades on cotton | BAYER AKTIENGESELLSCHAFT (DE) | 1992-03-03 | — | — | US | disclosed |
| EP-0292825-B1 | REACTIVE DYES | BAYER AG (DE) | 1991-08-07 | — | — | EP | disclosed |
| EP-0292825-A2 | Reactive dyes | BAYER AG (DE) | 1988-11-30 | — | — | EP | disclosed |
| EP-0139090-B1 | PROCESS FOR THE PRE-TREATMENT OF POLYIMIDES | SCHERING AKTIENGESELLSCHAFT (DE) | 1988-07-27 | — | — | EP | disclosed |
| US-4517254-A | ALKALI METAL HYDROXIDE, AMINOALKYLPOLYACID COMPOUNT | SCHERING AKTIENGESELLSCHAFT (DE) | 1985-05-14 | — | — | US | disclosed |
| EP-0139090-A1 | Process for the pre-treatment of polyimides | SCHERING AKTIENGESELLSCHAFT (DE) | 1985-05-02 | — | — | EP | disclosed |
| US-4248632-A | ACTIVATION OF A POLYMER SURFACE WITH A PALLADIUM COMPLEX SALT | SCHERING AKTIENGESELLSCHAFT (DE) | 1981-02-03 | — | — | US | disclosed |
| US-4118184-A | Stable liquid aqueous composition of a water-soluble fiber-reactive azo dyestuff, containing a buffer substance, the dyestuff having been prepared by diazotization with a nitrite and coupling in the absence of acid | HOECHST AKTIENGESELLSCHAFT (DE) | 1978-10-03 | — | — | US | disclosed |
| US-4009156-A | Hydroxynaphthalene trisazo dyestuffs | BAYER AKTIENGESELLSCHAFT (DT) | 1977-02-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110035886-A1 | Keratin Dyeing Compositions Comprising a Radical Scavenger and a Chelant and Use Thereof | KRT18, LPO, KRTCAP2 | ALOX5 994/4885PTGS2 1950/4885POLB 865/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.